Session

Emerging perspectives in non-alcholic fatty liver disease (NAFLD/NASH)

Defining the right patient for pharmacotherapy
Defining the right patient for pharmacotherapy

Emerging perspectives in non-alcholic fatty liver disease (NAFLD/NASH)

Identification of at risk patients and referal: Models of care
Identification of at risk patients and referal: Models of care

Emerging perspectives in non-alcholic fatty liver disease (NAFLD/NASH)

Complications in end-stage NAFLD
Complications in end-stage NAFLD

Emerging perspectives in non-alcholic fatty liver disease (NAFLD/NASH)

Item 1 - 3 / 3
1